We summarize the changes to ASCO's latest Antiemetic Guidelines update as well as their guidelines for chemotherapy-induced peripheral neuropathy (CIPN).
Then, we take a look at the PO decitabine approval and ponder the question, does low albumin decrease tolerability to some TKIs?
